HWM
PFE icon

HighMark Wealth Management’s Pfizer PFE Stock Holding History

HighMark Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
4,377
+32
+0.7% +$837 0.04% 120
2026
Q1 		$122K Sell
4,345
-48
-1% -$1.28K 0.05% 100
2025
Q4 		$109K Buy
4,393
+112
+3% +$2.82K 0.04% 108
2025
Q3 		$109K Buy
4,281
+32
+0.8% +$790 0.05% 112
2025
Q2 		$103K Buy
4,249
+2,350
+124% +$54.8K 0.05% 113
2025
Q1 		$48.1K Buy
1,899
+120
+7% +$3.14K 0.03% 129
2024
Q4 		$47.2K Sell
1,779
-2,291
-56% -$62.1K 0.03% 135
2024
Q3 		$118K Buy
4,070
+25
+0.6% +$729 0.06% 92
2024
Q2 		$113K Buy
4,045
+2,243
+124% +$61.8K 0.07% 89
2024
Q1 		$50K Buy
1,802
+125
+7% +$3.47K 0.03% 136
2023
Q4 		$48.3K Sell
1,677
-128
-7% -$3.87K 0.04% 135
2023
Q3 		$59.9K Buy
1,805
+18
+1% +$637 0.05% 105
2023
Q2 		$65.6K Buy
1,787
+18
+1% +$701 0.05% 101
2023
Q1 		$72.2K Buy
1,769
+16
+0.9% +$691 0.06% 109
2022
Q4 		$89.8K Buy
1,753
+12
+0.7% +$575 0.07% 82
2022
Q3 		$76K Buy
1,741
+14
+0.8% +$680 0.06% 77
2022
Q2 		$91K Buy
1,727
+52
+3% +$2.65K 0.07% 70
2022
Q1 		$87K Buy
1,675
+12
+0.7% +$623 0.06% 79
2021
Q4 		$98K Buy
1,663
+11
+0.7% +$545 0.06% 80
2021
Q3 		$71K Buy
1,652
+13
+0.8% +$576 0.05% 99
2021
Q2 		$64K Buy
1,639
+15
+0.9% +$583 0.05% 99
2021
Q1 		$59K Buy
1,624
+16
+1% +$568 0.05% 93
2020
Q4 		$59K Sell
1,608
-71
-4% -$2.6K 0.05% 89
2020
Q3 		$58K Buy
1,679
+67
+4% +$2.35K 0.05% 99
2020
Q2 		$50K Buy
1,612
+15
+0.9% +$510 0.05% 81
2020
Q1 		$49K Buy
1,597
+16
+1% +$545 0.06% 67
2019
Q4 		$58K Buy
+1,581
New +$56.3K 0.06% 77

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HighMark Wealth Management's PFE Position: Q2 2026 in Review

HighMark Wealth Management increased its Pfizer (PFE) stake by 0.74% in Q2 2026, buying an estimated $837 and bringing the position to 4,377 shares worth $105K. The position accounts for 0.04% of the portfolio, ranked #120.

HighMark Wealth Management first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $122K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • HighMark Wealth Management held 4,377 shares of Pfizer worth $105K as of Q2 2026.
  • HighMark Wealth Management bought 32 Pfizer shares in Q2 2026, an estimated $837.
  • Pfizer made up 0.04% of HighMark Wealth Management's portfolio in Q2 2026, its #120 holding.
  • HighMark Wealth Management first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • HighMark Wealth Management's Pfizer position peaked at $122K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on HighMark Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.